A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.

Int J Gynecol Cancer · 2017 · PMC5181123 · PMID 27636713

Europe PMC DOI

hedged sentence

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

marginally significantP = 0.069so close (0.05 < p ≤ 0.1)

Patients with high serum miRNA-125b expression showed a marginally significant increase in OS time ( P = 0.069) (Fig. 4 B).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.